The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study

Rituximab is used to eliminate B cells as a chimeric monoclonal antibody directed against CD20, a B-cell antigen expressed on B cells. To explore the impact of rituximab administered before transplantation, we implemented a retrospective, monocentric study and utilized real-world data collected at o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiya, Xie, Yiyu, Jiang, Ruoyu, Li, Huiyu, Wu, Heqing, Zhang, Yuqi, Li, Ling, Zhou, Shiyuan, Ma, Xiao, Tang, Zaixiang, He, Jun, Wu, Depei, Wu, Xiaojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471377/
https://www.ncbi.nlm.nih.gov/pubmed/36119024
http://dx.doi.org/10.3389/fimmu.2022.967026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471377/
https://www.ncbi.nlm.nih.gov/pubmed/36119024
http://dx.doi.org/10.3389/fimmu.2022.967026

Ejemplares similares